299.86

0.47% -1.42

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $299.86, with a volume of 160.12K. It is down -0.47% in the last 24 hours and down -2.57% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$301.28

Open:

$303.87

24h Volume:

160.12K

Relative Volume:

0.78

Market Cap:

$8.09B

Revenue:

$2.58B

Net Income/Loss:

$-778.69M

P/E Ratio:

-10.97

EPS:

-27.33

Net Cash Flow:

$223.75M

1W Performance:

-4.49%

1M Performance:

-2.57%

6M Performance:

+29.25%

1Y Performance:

-7.43%

1-Day Range:

$298.97

$307.78

1-Week Range:

$298.02

$314.97

52-Week Range:

$211.43

$373.69

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1134)

Industry

Medical Devices (145)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,700

Twitter

@BioRadLifeSci

Next Earnings Date

2024-10-30

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	299.86	8.13B	2.58B	-778.69M	223.75M	-27.33
ABT Abbott Laboratories	125.12	220.33B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	96.11	140.06B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	353.11	134.83B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	98.48	126.02B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	84.80	49.23B	5.88B	1.34B	799.60M	2.3489

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

07:34 AM

Why Bio Rad Laboratories Inc. (BUW) stock is a must watch tickerMarket Sentiment Report & Real-Time Buy Zone Alerts - DonanımHaber

07:34 AM

06:39 AM

Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Retail & Entry Point Confirmation Alerts - DonanımHaber

06:39 AM

05:52 AM

Published on: 2025-12-19 13:52:52 - DonanımHaber

05:52 AM

04:05 AM

Is Bio Rad Laboratories Inc. stock in correction or buying zone2025 Performance Recap & Low Drawdown Momentum Trade Ideas - DonanımHaber

04:05 AM

12:04 PM

Liquidity Mapping Around (BIO) Price Events - news.stocktradersdaily.com

12:04 PM

Dec 18, 2025

Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action - Улправда

Dec 18, 2025

Guidance Update: Will Bio Rad Laboratories Inc. stock gain from government policies2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда

Dec 18, 2025

Is Bio Rad Laboratories Inc. stock a safe investment in uncertain marketsJuly 2025 Rallies & Risk Controlled Daily Plans - Улправда

Dec 18, 2025

Dec 17, 2025

Published on: 2025-12-18 04:48:11 - moha.gov.vn

Dec 17, 2025

Multi Omics Platform Market Outlook 2025-2032: Key Trends, Size - openPR.com

Dec 17, 2025

Dec 16, 2025

DNA/RNA Extraction Kit Market to Reach US$ 5.12 Billion by 2033 - openPR.com

Dec 16, 2025

Fragment Analysis Market 2025-2032: Growth Overview, Facts & - openPR.com

Dec 16, 2025

Dec 15, 2025

Biodesix and Bio-Rad Laboratories Team Up on Droplet Digital PCR Assays - Medical Product Outsourcing

Dec 15, 2025

Is Bio-Rad (BIO) Quietly Repositioning Its Moat Around Automation‑Led Blood Diagnostics? - Sahm

Dec 15, 2025

IVD Diagnostic Molecule Raw Enzymes Market Forecast to Grow at 7.13% CAGR by 2034 - GlobeNewswire Inc.

Dec 15, 2025

MASTERINVEST Kapitalanlage GmbH Acquires New Shares in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Dec 15, 2025

United States DNA Sequencing Market 2031 | Growth Drivers, Key - openPR.com

Dec 15, 2025

Dec 14, 2025

Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for antibody conjugation to StarBright Dyes - MSN

Dec 14, 2025